Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreas Adenocarcinomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT06467565
What this trial is testing

NALIRIFOX as Induction Therapy in LAPC

Who this might be right for
Pancreatic Ductal Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06573398
What this trial is testing

Radiotherapy With Sequential Chemotherapy Combined With PD-1 Inhibitor and Thymalfasin for BRPC

Who this might be right for
Carcinoma, Pancreatic Ductal
Ruijin Hospital 20
Testing effectiveness (Phase 2)Study completedNCT02426281
What this trial is testing

Nab-pacliatxel Plus Gemcitabine in Korean Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Samsung Medical Center 111
Not applicableStudy completedNCT06344299
What this trial is testing

Predictors for Low Rates of Surgical Resection in Elderly Patients With Resectable Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Fudan University 5,302
Not applicableStudy completedNCT03794128
What this trial is testing

Personalized Neoantigen Cancer Vaccines

Who this might be right for
Non Small Cell Lung CancerColorectal CancerGastroesophageal Adenocarcinoma+2 more
Gritstone bio, Inc. 93
Early research (Phase 1)Study completedNCT06464965
What this trial is testing

Clinical Study of Cord Blood-Derived CAR-NK Cells in Gastric Cancer and Pancreatic Cancer

Who this might be right for
Gastric CancerPancreas Adenocarcinoma
Zhejiang Provincial People's Hospital 9
Not applicableLooking for participantsNCT07255001
What this trial is testing

Using Strength Tests to Better Understand How Pancreatic Cancer Affects Muscle Mass and Quality of Life

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Hand Grip Strength
British Columbia Cancer Agency 50
Testing effectiveness (Phase 2)Study completedNCT03410030
What this trial is testing

Trial of Ascorbic Acid (AA) + Nanoparticle Paclitaxel Protein Bound + Cisplatin + Gemcitabine (AA NABPLAGEM)

Who this might be right for
Pancreatic CancerPancreas CancerPancreatic Adenocarcinoma Resectable+2 more
HonorHealth Research Institute 17
Large-scale testing (Phase 3)Study completedNCT02993731
What this trial is testing

Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Carcinoma, Pancreatic Ductal
Sumitomo Pharma America, Inc. 1,134
Early research (Phase 1)Study completedNCT00574977
What this trial is testing

Safety Study of Modified Vaccinia Virus to Cancer

Who this might be right for
MelanomaBreast CancerHead and Neck Squamous Cell Cancer+3 more
David Bartlett 26
Testing effectiveness (Phase 2)Study completedNCT01150630
What this trial is testing

Gemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
IRCCS San Raffaele 98
Testing effectiveness (Phase 2)Looking for participantsNCT07101679
What this trial is testing

GnP RegimenCombined With Serplulimab and Stereotactic Body Radiation Therapy as First-line Treatment for Locally Advanced Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Ductal Adenocarcinoma
West China Hospital 23
Early research (Phase 1)Active Not RecruitingNCT03821935
What this trial is testing

Study to Determine the Safety, Tolerability, Pharmacokinetics and Recommended Phase 2 Dose (RP2D) of Livmoniplimab (ABBV-151) as a Single Agent and in Combination With Budigalimab (ABBV-181) in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumors Cancer
AbbVie 364
Not applicableActive Not RecruitingNCT06132087
What this trial is testing

PROACTIVE: Surgical Resection Outcomes in Locally Advanced and Unresectable Pancreatic Cancer After Neoadjuvant Chemotherapy

Who this might be right for
Locally Advanced Pancreatic AdenocarcinomaStage III Pancreatic Cancer American Joint Committee on Cancer v8Unresectable Pancreatic Adenocarcinoma
University of Southern California 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT05102721
What this trial is testing

Trial of Immunotherapy With Avelumab and Pepinemab As Second Line For Patients With Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Vaccinex Inc. 48
Testing effectiveness (Phase 2)Study completedNCT05262855
What this trial is testing

Study of [68Ga]FAPI-46 PET in Patients With Pancreatic Ductal Carcinoma

Who this might be right for
PDAC - Pancreatic Ductal AdenocarcinomaFAP
SOFIE 63
Not applicableNot Yet RecruitingNCT05895214
What this trial is testing

Mesopancreas Study in Pancreatic Cancer

Who this might be right for
PDACPancreatoduodenectomyMargin, Resection+2 more
Heinrich-Heine University, Duesseldorf 500
Large-scale testing (Phase 3)Looking for participantsNCT07621718
What this trial is testing

Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )

Who this might be right for
Pancreatic CancerPancreatic Cancer MetastaticPDAC+5 more
Revolution Medicines, Inc. 670
Testing effectiveness (Phase 2)Ended earlyNCT05239182
What this trial is testing

9-ING-41 Plus Retifanlimab and Gemcitabine/Nab-Paclitaxel in Patients With Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
Anwaar Saeed 7
Large-scale testing (Phase 3)Looking for participantsNCT07081360
What this trial is testing

Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer

Who this might be right for
Pancreas CancerPeriampullary CancerPeriampullary Carcinoma Resectable+3 more
Minia University 262
Next Page